News
Serum levels of C1M, a biochemical marker of type I collagen degradation, may predict progression of total joint damage in ...
Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.
6h
TheHealthSite.com on MSNPfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...
4h
Cryptopolitan on MSNGlobal companies have lost $320 billion to geopolitical and economic chaosGlobal companies have been hit with a brutal $320 billion in lost profit since 2017, and it has nothing to do with bad ...
Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...
Explore more
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...
Researchers looked at how the vaccine affected patients' corneas - the clear front part of the eye that allows light to come in ...
Almost 3,500 listed companies globally that have annual revenues above $1bn lost a combined $320bn in profit during periods of geopolitical and macro volatility, a study by EY-Parthenon, the strategy ...
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production ...
With his three decades of experience in healthcare and technology companies, Gilad will play a pivotal role in the execution of our growth strategy, and I am delighted to welcome him to the Protalix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results